Previous 10 |
Castle Biosciences, Inc. (Nasdaq: CSTL), announced today the closing of its previously announced initial public offering of 4,600,000 shares of its common stock, which includes 600,000 shares sold pursuant to the exercise in full by the underwriters of their option to purchase additional shar...
Eight companies and two SPACs entered the public market this week. Health and tech companies Health Catalyst, Castle Biosciences, and Livongo dominated while solar energy installer Sunnova and sporting events company Wanda Sports Group fell flat. Health Catalyst, which provides a data analyt...
With 65% revenue growth, Castle Biosciences (CSTL) will be a name to be followed carefully after the IPO. The company sells a product that does not seem to need a lot of marketing efforts. Additionally, several academic journals featured the company's technology, and Medicare is responsible fo...
Castle Biosciences ( CSTL ) has priced its IPO of 4M common shares at $16, for gross proceeds of ~$64M. More news on: Castle Biosciences, Healthcare stocks news, IPO News, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NASDAQ Market:
Castle Biosciences Inc. Website:
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Canaccord Genuity 44 th Annual Growth Conference on Tuesday, Aug. 13, 2024, at ...
Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024. Compan...